A

ADMA Biologics, Inc. Tech Stack

FDA-licensed plasma fractionation and source collection for immune globulin therapies

Biotechnology Research Ramsey, NJ 501–1,000 employees Founded 2004 Public Company

ADMA Biologics manufactures three FDA-approved plasma-derived immune globulins (BIVIGAM, ASCENIV, NABI-HB) and operates both a fractionation facility and source plasma collection network. The company's tech stack and project backlog are operationally focused—SAP implementations, process validation, and cGMP compliance dominate—with manufacturing roles outnumbering engineering 6.5-to-1, signaling a capital-intensive, regulated-manufacturing business rather than a software or R&D startup.

Tech Stack 14 technologies

Core StackSAP Blackline Outlook Word Excel GroupWise CMMS LIMS HPLC GCP Microsoft Office Microsoft Project PowerPoint Teams

What ADMA Biologics, Inc. Is Building

◆Challenges

Ensuring compliance with sops
Maintaining cgmp compliance
Workflow inefficiencies
Monitoring donor flow efficiency
Reducing quality errors
Training compliance gaps
Audit readiness
Ensuring supply availability
Staffing issues
Improving workflow efficiency

▲Active Projects

Process validation
Capa training plans
Qa sop review
Month end close optimization initiative
Monthly financial consolidation
Bpdr reporting
Freezer temperature incident resolution
Cross training program
Implementation of new functionalities in sap
Technology transfer and scale-up

Hiring Activity

Steady110 roles · 35 in 30d

Department

Manufacturing

39

Healthcare

28

Ops

16

Engineering

6

Finance

4

Research

4

Sales

3

Operations

2

Seniority

Junior

44

Mid

43

Manager

11

Director

5

Senior

5

Intern

1

Lead

1

Notable leadership hires: Regional Business Director

Company intelligence

Find more companies like ADMA Biologics, Inc. by tech stack, pain points and active projects

Get started free

About ADMA Biologics, Inc.

ADMA Biologics is a public, end-to-end biopharmaceutical manufacturer headquartered in Ramsey, NJ with core operations in Boca Raton, FL. The company manufactures and markets three FDA-approved plasma-derived biologics for immunodeficient and at-risk populations. It operates an FDA-licensed plasma fractionation and purification facility in Boca Raton and runs ADMA BioCenters, a subsidiary that collects source plasma for use in its own manufacturing. The company targets niche immunology and infectious disease markets, serving immunocompromised patient populations. With 501–1,000 employees and active hiring across manufacturing, healthcare, and operations roles, ADMA is scaling production and compliance infrastructure.

HeadquartersRamsey, NJ

Company Size501–1,000 employees

Founded2004

Hiring MarketsUnited States

Frequently Asked Questions

What does ADMA Biologics manufacture?

ADMA manufactures three FDA-approved plasma-derived immune globulins: BIVIGAM for primary humoral immunodeficiency, ASCENIV (10% liquid formulation) for immunodeficiency treatment, and NABI-HB for hepatitis B immunity. All products are produced at its FDA-licensed fractionation facility in Boca Raton, Florida.